Clinical evidence supports dose escalation every four weeks for optimal results
In order to find out the cytoprotective mechanisms of ursodeoxycholic acid (UDCA) in PBC, Kawata et al
Mounjaro (tirzepatide), on the other hand, activates GLP-1 and GIP , which generally produces stronger weight loss outcomes than GLP-1 alone
The three major hurdles that prevent faster and vast progress such as less sustainable behavior change, medication side effects, and medication cost
Aug 22,2025 Bestchrom Application of GLP-1 drugs GLP-1 drugs are gaining great attention in recent years for its significant efficacy in diabetes treatment and weight control
Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barretts oesophagus: a prospective, international, randomised controlled trial